APPLICATION
ANDA072220
TYPE
ANDA
ORIGINAL APPROVAL
1988-08-26
LATEST ACTION
2016-12-16
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
CLORAZEPATE DIPOTASSIUMDiscontinued
CLORAZEPATE DIPOTASSIUM 7.5MG · CAPSULE · ORAL
Approval history
2016-12-16Labeling · Supplement 10 · standardAP
1999-08-24Labeling · Supplement 4AP
1990-09-05Labeling · Supplement 1AP
1988-08-26OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.